Literature DB >> 650707

Immunologic studies on a pancreatic oncofetal protein.

A A Mihas.   

Abstract

Immunization of rabbits with a human fetal pancreas extract produced precipitating antibody against an antigen present only in fetal pancreas and extracts of human pancreatic carcinoma. Pancreatic oncofetal protein (POP) migrated on immunoelectrophoresis in the alpha1-alpha2 region, thus making possible its detection by counterimmunoelectrophoresis. POP was found in the 12,000 X g supernatant of fetal pancreas and could be precipitated with (NH4)2SO4 at concentrations between 30 and 45%. The antigen was partially purified by consecutive centrifugation at 12,000 X g, 40% (NH4)2SO4 precipitation, and ion-exchange chromatography. Treatment of the POP with trypsin completely abolished its antigenic activity; this suggested that the antigen was a protein or a moiety closely associated with protein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 650707     DOI: 10.1093/jnci/60.6.1439

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

1.  Serologic markers in the diagnosis and management of pancreatic carcinoma.

Authors:  D K Podolsky
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

2.  Human pancreatic secretory protein profiles in the search for tumor markers.

Authors:  T T White; B J Allan; J J Schilling; H Miyashita
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

3.  Monoclonal antibody defines CA 19-9 in pancreatic juices and sera.

Authors:  W H Schmiegel; C Kreiker; W Eberl; R Arndt; M Classen; H Greten; K Jessen; H Kalthoff; N Soehendra; H G Thiele
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

4.  Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.

Authors:  K Nishida; M Sugiura; T Yoshikawa; M Kondo
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

5.  Reactivity of monoclonal anti-human pancreatic carcinoma antibodies AR2-20 and AR1-28 with tumors of nonpancreatic origin.

Authors:  J Chin; R Zuna; F Miller
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.